Skip to main content

Lee Ann's Form 4 filing

Coya Therapeutics, Inc.COYA · filed Mar 5, 2024

Accession no.
0001493152-24-008916
Filed
Mar 5, 2024
Trade date
Aug 22, 2023
Filing delay
196 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $3.62K. It was filed 196 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lee AnnCIK 0001953080Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 22, 2023Common Stock, par value $0.0001 per sharePPurchaseAcquired+1,000$3.62F1+$3,62017,479Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)